The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: A retrospective case-control study

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 3, 2013, Pages 317-320

  Deloughery, Emma P ^a   Lenfesty, Barbara ^a   Deloughery, Thomas G ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NRC 3   (United States)

Author keywords

intracranial haemorrhage; plasma; recombinant factor VIIa; warfarin

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

BRAIN HEMORRHAGE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HUMAN; INJURY SCALE; INTERNATIONAL NORMALIZED RATIO; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; SUBDURAL HEMATOMA; TRAUMATIC BRAIN INJURY;

AGED; ANTICOAGULANTS; BRAIN INJURIES; CASE-CONTROL STUDIES; COAGULANTS; FACTOR VIIA; FEMALE; HUMANS; INJURY SEVERITY SCORE; INTRACRANIAL HEMORRHAGE, TRAUMATIC; MALE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WARFARIN;

EID: 84875822627     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835cc16b     Document Type: Review

References (11)

1. Nyquist P. Management of acute intracranial and intraventricular hemorrhage. Crit Care Med 2010; 38:946-953.
2. McMillian WD, Rogers FB. Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. J Trauma 2009; 66:942-950.
3. Elliott J, Smith M. The acute management of intracerebral hemorrhage: a clinical review. Anesth Analg 2010; 110:1419-1427.
4. Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Ann Intern Med 2011; 154:516-522.
5. Dager WE, King JH, Regalia RC, Williamson D, Gosselin RC, White RH, et al. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin. Pharmacotherapy 2006; 26:1091-1098. (Pubitemid 44167818)
6. Skolnick BE, Mathews DR, Khutoryansky NM, Pusateri AE, Carr ME. Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood 2010; 116:693-701.
7. Sarode R, Matevosyan K, Bhagat R, Rutherford C, Madden C, Beshay JE. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. J Neurosurg 2012; 116:491-497.
8. Brown CV, Sowery L, Curry E, Valadka AB, Glover CS, Grabarkewitz K, et al. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center. Am Surg 2012; 78:57-60.
9. Nishijima DK, Dager WE, Schrot RJ, Holmes JF. The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage. Acad Emerg Med 2010; 17:244-251.
10. Illanes S, Zhou W, Schwarting S, Heiland S, Veltkamp R. Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage. Stroke 2011; 42:191-195.
11. Pinner NA, Hurdle AC, Oliphant C, Reaves A, Lobo B, Sills A. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII. World Neurosurg 2010; 74:631-635.